News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
496,075 Results
Type
Article (28762)
Company Profile (72)
Press Release (467234)
Multimedia
Podcasts (111)
Webinars (13)
Section
Business (147077)
Career Advice (1514)
Deals (24146)
Drug Delivery (69)
Drug Development (58155)
Employer Resources (105)
FDA (10979)
Job Trends (10419)
News (243210)
Policy (21420)
Tag
Academia (1797)
Academic (1)
Accelerated approval (11)
Adcomms (16)
Allergies (94)
Alliances (37423)
ALS (110)
Alzheimer's disease (1220)
Antibody-drug conjugate (ADC) (177)
Approvals (11148)
Artificial intelligence (325)
Autoimmune disease (81)
Automation (26)
Bankruptcy (207)
Best Places to Work (8658)
BIOSECURE Act (9)
Biosimilars (113)
Biotechnology (49)
Bladder cancer (104)
Brain cancer (32)
Breast cancer (410)
Cancer (3234)
Cardiovascular disease (294)
Career advice (1304)
Career pathing (29)
CAR-T (153)
CDC (22)
Cell therapy (484)
Cervical cancer (22)
Clinical research (49548)
Collaboration (1143)
Compensation (968)
Complete response letters (23)
COVID-19 (1826)
CRISPR (65)
C-suite (427)
Cystic fibrosis (102)
Data (4337)
Decentralized trials (2)
Denatured (36)
Depression (74)
Diabetes (363)
Diagnostics (4617)
Digital health (28)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (152)
Drug pricing (93)
Drug shortages (20)
Duchenne muscular dystrophy (158)
Earnings (71668)
Editorial (41)
Employer branding (13)
Employer resources (93)
Events (88635)
Executive appointments (648)
FDA (12993)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (16)
Funding (915)
Gene editing (142)
Generative AI (30)
Gene therapy (424)
GLP-1 (694)
Government (3003)
Grass and pollen (6)
Guidances (340)
Healthcare (13637)
HIV (42)
Huntington's disease (27)
IgA nephropathy (60)
Immunology and inflammation (164)
Immuno-oncology (12)
Indications (55)
Infectious disease (1977)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (65)
Intellectual property (148)
Interviews (279)
IPO (12775)
IRA (33)
Job creations (2135)
Job search strategy (1068)
Kidney cancer (10)
Labor market (46)
Layoffs (313)
Leadership (30)
Legal (5131)
Liver cancer (62)
Longevity (8)
Lung cancer (481)
Lymphoma (239)
Machine learning (18)
Management (37)
Manufacturing (470)
MASH (126)
Medical device (9062)
Medtech (9087)
Mergers & acquisitions (12132)
Metabolic disorders (850)
Multiple sclerosis (111)
NASH (16)
Neurodegenerative disease (169)
Neuropsychiatric disorders (40)
Neuroscience (1984)
NextGen: Class of 2025 (4408)
Non-profit (3467)
Now hiring (17)
Obesity (354)
Opinion (201)
Ovarian cancer (103)
Pain (118)
Pancreatic cancer (142)
Parkinson's disease (177)
Partnered (15)
Patents (292)
Patient recruitment (213)
Peanut (34)
People (35948)
Pharmaceutical (16)
Pharmacy benefit managers (14)
Phase I (14425)
Phase II (21491)
Phase III (17504)
Pipeline (2915)
Policy (165)
Postmarket research (2108)
Preclinical (6462)
Press Release (41)
Prostate cancer (183)
Psychedelics (29)
Radiopharmaceuticals (192)
Rare diseases (509)
Real estate (3478)
Recruiting (41)
Regulatory (15881)
Reports (26)
Research institute (1674)
Resumes & cover letters (230)
Rett syndrome (18)
RNA editing (9)
RSV (47)
Schizophrenia (103)
Series A (145)
Series B (96)
Service/supplier (7)
Sickle cell disease (66)
Special edition (15)
Spinal muscular atrophy (93)
Sponsored (27)
Startups (2094)
State (1)
Stomach cancer (10)
Supply chain (54)
Tariffs (45)
The Weekly (74)
Vaccines (625)
Venture capital (50)
Weight loss (228)
Women's health (42)
Worklife (14)
Date
Last 7 days (509)
Last 30 days (2713)
Last 365 days (24240)
2025 (22319)
2024 (26619)
2023 (29801)
2022 (37313)
2021 (40119)
2020 (38560)
2019 (33095)
2018 (24471)
2017 (22821)
2016 (22215)
2015 (26181)
2014 (21424)
2013 (18214)
2012 (18602)
2011 (18463)
2010 (17411)
Location
Africa (613)
Alabama (60)
Alaska (4)
Arizona (159)
Arkansas (8)
Asia (27044)
Australia (4617)
California (7810)
Canada (2226)
China (678)
Colorado (330)
Connecticut (371)
Delaware (222)
Europe (66206)
Florida (1191)
Georgia (245)
Idaho (30)
Illinois (551)
India (43)
Indiana (389)
Iowa (9)
Japan (271)
Kansas (91)
Kentucky (28)
Louisiana (14)
Maine (49)
Maryland (984)
Massachusetts (5805)
Michigan (213)
Minnesota (373)
Mississippi (1)
Missouri (95)
Montana (14)
Nebraska (13)
Nevada (79)
New Hampshire (34)
New Jersey (2272)
New Mexico (14)
New York (2095)
North Carolina (1378)
North Dakota (7)
Northern California (3766)
Ohio (234)
Oklahoma (15)
Oregon (23)
Pennsylvania (1605)
Puerto Rico (7)
Rhode Island (27)
South America (864)
South Carolina (50)
Southern California (3073)
Tennessee (117)
Texas (1147)
United States (28347)
Utah (233)
Vermont (1)
Virginia (159)
Washington D.C. (62)
Washington State (653)
West Virginia (3)
Wisconsin (70)
Wyoming (2)
496,075 Results for "hyman phelps and mcnamara p c".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C. A similar dynamic is now playing out between Eli Lilly and Novo Nordisk in the obesity space, with some key differences.
November 18, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors
August 7, 2025
·
3 min read
Press Releases
TOLREMO therapeutics Welcomes Multiple Myeloma Leader Kenneth C. Anderson to its Scientific Advisory Board
October 30, 2025
·
4 min read
Press Releases
/C O R R E C T I O N from source -- argenx Canada Inc./
November 6, 2025
·
7 min read
Press Releases
/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./
October 21, 2025
·
8 min read
Press Releases
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
November 20, 2025
·
3 min read
Press Releases
AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
September 18, 2025
·
10 min read
Press Releases
OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family
October 28, 2025
·
2 min read
Press Releases
SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure
November 18, 2025
·
10 min read
Press Releases
OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Final FDA Type C Meeting December 11, 2025 - biomarker data to be available October 10, 2025 FDA/Osteosarcoma Institute Workshop narrows focus for OST-HER2 overall survival, biomarker correlation & canine osteosarcoma data
October 17, 2025
·
5 min read
1 of 49,608
Next
